JTCC researchers play important role in groundbreaking study that may change transplant practices

Phase 3 study finds no significant survival difference between blood stem cells and bone marrow transplants for cancer patients

2012-11-20

(Press-News.org) Hackensack, NJ (November 20, 2012) – Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on October 18 that may change the current blood and marrow transplantation practices. The phase 3, multicenter study compared harvesting stem cells from bone marrow rather than blood and suggests there are benefits to both approaches, but no survival differences between the two methods.

Over the past 10 years, 75 percent of stem cell transplants from unrelated adult donors have used peripheral blood stem cells rather than those harvested from bone marrow without clinical data to support this shift. The study did not find significant survival differences between peripheral-blood stem-cell and bone marrow transplantation from unrelated donors.

"We did find that peripheral-blood stem cells may reduce the risk of graft failure, whereas bone marrow may reduce the risk of developing chronic graft-versus-host disease (GVHD), a complication that is frequently debilitating," said study author Scott Rowley, M.D., Chief, Blood and Marrow Transplantation at John Theurer Cancer Center.

GVHD is a common complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient's body. This can cause a variety of serious side effects, such as skin rashes, liver problems and diarrhea. Chronic GVHD usually starts three months after transplant and can last a lifetime. Its symptoms may include chronic pain, dry eyes and mouth, fatigue, skin rash, weight loss.

"As one of the 10 largest blood and marrow transplant programs in the nation, we remain committed to being on the forefront of the latest transplantation research and treatment," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services, John Theurer Cancer Center.

### To view the complete study, visit the New England Journal of Medicine online.

About John Theurer Cancer Center at Hackensack University Medical Center John Theurer Cancer Center at Hackensack University is among the nation's top 50 U.S. News and World Report Best Hospitals for cancer – the highest-ranked in New Jersey with this designation. It is New Jersey's largest and most comprehensive cancer center dedicated to the diagnosis, treatment, management, research, screenings, preventive care, as well as survivorship of patients with all types of cancer.

Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. The 14 specialized divisions feature a team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. The John Theurer Cancer Center provides comprehensive multidisciplinary care, state of the art technology, access to clinical trials, compassionate care and medical expertise—all under one roof. For more information please visit jtcancercenter.org.

ELSE PRESS RELEASES FROM THIS DATE:

Nanotech device mimics dog's nose to detect explosives

2012-11-20

(Santa Barbara, CA —) Portable, accurate, and highly sensitive devices that sniff out vapors from explosives and other substances could become as commonplace as smoke detectors in public places, thanks to researchers at University of California, Santa Barbara. Researchers at UCSB, led by professors Carl Meinhart of mechanical engineering and Martin Moskovits of chemistry, have designed a detector that uses microfluidic nanotechnology to mimic the biological mechanism behind canine scent receptors. The device is both highly sensitive to trace amounts of certain vapor molecules, ...

Nanomedicine breakthrough could improve chemotherapy for childhood cancer

2012-11-20

In a world-first, researchers from the Australian Centre for Nanomedicine at the University of New South Wales (UNSW) in Sydney have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five. Neuroblastoma is an aggressive childhood cancer that often leaves survivors with lingering health problems due to the high doses of chemotherapy drugs required for treatment. Anything that can potentially reduce these doses is considered an important development. The UNSW researchers developed a non-toxic nanoparticle ...

Rituximab shows promise for clinical problems tied to antiphospholipid antibodies

2012-11-20

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism. "This is the first study to systematically analyze rituximab in aPL-positive patients. Rituximab may have a role in treating a subgroup of aPL patients," said Doruk ...

VTT: A low-carbon Finland is a great challenge, but an achievable one

2012-11-20

VTT specialists have assessed Finland's chances of achieving the 80% greenhouse gas emission reduction targets. The EU's goal for 2050 is to reduce emissions by at least 80% from the level of 1990. The goal is a tough one for Finland, but possible to achieve as long as all sectors that produce or consume energy take part. On top of this, all greenhouse gas emissions must be reduced. Finland requires new technological solutions for industrial activity, for the transport of people, goods and services, and for housing and working methods. If clean forms of energy and the ...

Europe must not lose momentum in marine biodiversity research

2012-11-20

A new Marine Board Future Science Brief presents a roadmap for marine biodiversity science in Europe and warns against complacency. The ocean provides 95% of the habitable space on Earth and harbours a vast diversity of life. Biodiversity underpins the health of the oceans and their productive ecosystems which are essential for human well-being and prosperity. But marine life is under significant threat from climate change and from increasing human impacts including pollution, overfishing and ocean acidification. Marine biodiversity research and its role in supporting ...

Gastric bypass surgery: Follow up as directed to lose more

2012-11-20

Gastric bypass patients who attended five follow-up office visits in two years as recommended by their surgeons lost nearly twice as much weight (113 lbs. vs. 57 lbs.) as patients who attended only two follow-up visits, according to a University of Pennsylvania School of Nursing study in Obesity Surgery. The global epidemic of overweight and obese people is estimated to include 1.7 billion individuals, with two-thirds of those living in the U.S. Measurement of body mass index (BMI), a calculation of height and weight, classifies obesity. Patients with severe obesity ...

Sweat glands play major role in healing human wounds, U-M research shows

2012-11-20

ANN ARBOR, Mich. — Turns out the same glands that make you sweat are responsible for another job vital to your health: they help heal wounds. Human skin is rich with millions of eccrine sweat glands that help your body cool down after a trip to the gym or on a warm day. These same glands, new University of Michigan Health System research shows, also happen to play a key role in providing cells for recovering skin wounds – such as scrapes, burns and ulcers. The findings were released online ahead of print in the American Journal of Pathology. "Skin ulcers – including ...

King's Water Research Group co-convenes global conference on food and water security

2012-11-20

A team of experts from King's College London have played a major role in delivering an international conference on food and water security in Qatar this week. The Food Security in Dry Lands (FSDL) conference has been organised in the run up to the forthcoming UN climate meeting (COP18) later this month, where 'climate-smart' agriculture is expected to be a key focus. The King's Water Research Group have contributed to the new Doha Declaration, which states that by 2022, participating countries -Qatar, Kenya, Tanzania, Chad, Egypt, Jordan, Saudi Arabia, South Africa, Nigeria, ...

Discovery of molecular pathway of Alzheimer's disease reveals new drug targets

2012-11-20

The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for drug discovery that could be exploited to combat the disease. The study gives the most detailed understanding yet of the complex processes leading to Alzheimer's. Alzheimer's disease is associated with plaques made up of deposits of a molecule called amyloid between brain cells, which leads to the formation of tangles of twisted fibres made from a molecule called tau, found inside the brain cells. This causes the death ...

Frequency of alcohol consumption and cardiovascular risk factors

2012-11-20

Critique 096: Frequency of alcohol consumption and cardiovascular risk factors: implications for drinking guidelines 20 November 2012 Read the full critique here: http://www.bu.edu/alcohol-forum/critique-096-frequency-of-alcohol-consumption-and-cardiovascular-risk-factors-implications-for-drinking-guidelines-20-november-2012/ The purpose of this paper was to examine whether drinkers who consume lower-risk amounts on more frequent occasions have favourable risk factor profiles compared with those who drink more per occasion but less frequently. The authors also discuss ...

JTCC researchers play important role in groundbreaking study that may change transplant practices

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: